By Matthew Perrone | AP Health Writer WASHINGTON—US officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
WASHINGTON—US officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
Physicians who treat Alzheimer’s say the approval is an important step after decades of failed experimental treatments. The new drug’s approval was expected after an outside panel of FDA advisors unanimously voted in favor of its benefits at a public meeting last month. That endorsement came despite several questions from FDA reviewers about how Lilly studied the drug, including allowing patients to discontinue treatment after their plaque reached very low levels.
More than 6 million Americans have Alzheimer’s. Only those with early or mild disease will be eligible for the new drug, and an even smaller subset are likely to undergo the multi-step process needed to get a prescription. Kisunla is infused once a month compared to Leqembi’s twice-a-month regimen, which could make things easier for caregivers who bring their loved ones to a hospital or clinic for treatment.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Singaporean stars Brian Ng, David Matthew, Raynold Tan visit the Philippines for collab projectLatest Philippine news from GMA News and 24 Oras. News, weather updates and livestreaming on Philippine politics, regions, showbiz, lifestyle, science and tech.
Read more »
Unilab lauds FDA’s proactive measures vs fake drugsPharmaceutical and healthcare company Unilab Inc. lauded the Food and Drug Administration (FDA) for taking proactive measures to protect the public from the perils of purchasing fake medicines.
Read more »
FDA warns public vs 6 counterfeit medsSunStar Publishing Inc.
Read more »
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA saysLatest Philippine news from GMA News and 24 Oras. News, weather updates and livestreaming on Philippine politics, regions, showbiz, lifestyle, science and tech.
Read more »
FDA miisyo og pahimangno batok sa 6 ka fake medicinesSunStar Publishing Inc.
Read more »
FDA advisers back Alzheimer's drug to slow diseaseWASHINGTON, D.C. — A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment's expected approval for people with mild dementia caused by the brain-robbing disease.
Read more »